Clinical Trial

Male Lichen Sclerosus - Risk Factors, Treatment, and Impact on Quality of Life

Recruiting
View on ClinicalTrials.gov →
Summary
This observational study aims to evaluate routine treatment outcomes in men with lichen sclerosus (LS), including a long-term follow-up to assess disease progression and histopathological changes. The study also investigates potential risk factors for LS and the disease's impact on quality of life and sexual health.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-19; most recent amendment 2026-02-09.
Status change: Not Yet Recruiting → Recruiting 2026-02-09
Trial Details
NCT Number NCT06984263
Lead Sponsor Region Västerbotten
Collaborators: Umeå University
Conditions Lichen Sclerosus
Enrollment 300 participants
Start Date 2025-10-06
Primary Completion 2028-10 (estimated)
Study Completion 2038-10 (estimated)
Updated on ClinicalTrials.gov 2026-02-10